Found 6 articles for: "semaglutide"
GLP-1 Receptor Agonist Paradox in Hair Biology: A Biphasic dWAT–Follicle Signaling Hypothesis
September 2026 | Volume 25 | Issue 9 | Features | 874 | Copyright © September 2026
GLP-1 Receptor Agonists in Overweight and Obese Patients With Hidradenitis Suppurativa
February 2026 | Volume 25 | Issue 2 | Features | 178 | Copyright © February 2026
Prevalence of Pruritus in Type 2 Diabetic Patients on GLP-1 Agonist Therapy
January 2026 | Volume 25 | Issue 1 | Editorials | e24 | Copyright © January 2026
Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists: A FAERS Database Analysis From 2018-2024
January 2026 | Volume 25 | Issue 1 | Original Article | 11 | Copyright © January 2026
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for conditions beyond type 2 diabetes, including psoriasis and hidradenitis suppurat...
Read MoreConsiderations on Concurrent Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Isotretinoin
June 2025 | Volume 24 | Issue 6 | Editorials | 638 | Copyright © June 2025
Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports
April 2023 | Volume 22 | Issue 4 | Case Reports | 413 | Copyright © April 2023
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of antidiabetic agents that work by inducing insulin secretion and inhibiting release of glucagon in a glucose-dependent manner. They...
Read More
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.